Abstract

In this article, the affiliation details for Dominic Witzke were incorrectly given as ’Department of Infectious Diseases, Evangelisches Klinikum Bethel, Bielefeld, Germany’, but should have read instead ’Department of Anaesthesiology, Intensive Care, Protestant Hospital of the Bethel Foundation, University Hospital of Bielefeld, Campus Bielefeld-Bethel, University of Bielefeld, Germany’. Additionally, the correct full name of Markus Weigand is Markus Alexander Weigand. Finally, the wrong Supplementary file 1 was originally published with this article; it has now been replaced with the correct file containing the missing eFigure1. The authors apologize for these mistakes. The original article has been corrected.

Original languageEnglish
JournalIntensive Care Medicine
Volume48
Issue number5
Pages (from-to)646-647
Number of pages2
ISSN0342-4642
DOIs
Publication statusPublished - 05.2022

Research Areas and Centers

  • Academic Focus: Center for Infection and Inflammation Research (ZIEL)

DFG Research Classification Scheme

  • 2.21-05 Immunology
  • 2.22-09 Pharmacology
  • 2.22-31 Clinical Infectiology and Tropical Medicine

Fingerprint

Dive into the research topics of 'Correction to: Effect of therapeutic drug monitoring-based dose optimization of piperacillin/tazobactam on sepsis-related organ dysfunction in patients with sepsis: a randomized controlled trial (Intensive Care Medicine, (2022), 48, 3, (311-321), 10.1007/s00134-021-06609-6)'. Together they form a unique fingerprint.

Cite this